뇌심부 자극 시장 보고서 : 자극 유형별, 제품별, 용도, 최종사용자별, 지역별(2026-2034년)

The global deep brain stimulation market size reached USD 1.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 7.83% during 2026-2034. The rising occurrence of various motor and neurological disorders among the masses, growing acceptance of minimally invasive (MI) surgical methods, and construction of hospitals, nursing homes, and clinics across the globe represent some of the key factors driving the market.

Deep brain stimulation (DBS) refers to the surgical procedure that aids in treating various neurological and movement-associated disorders, such as Parkinson's disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves implanting electrodes within certain areas of the brain to produce electrical impulses for regulating abnormal impulses in the brain. It relies on a pacemaker-like device, called a programmable generator, placed under the skin of the upper chest of the patient along with a wire that connects the device to the electrodes. It blocks the formation of neurological dysfunction, causing impulses, and aids the brain in functioning effectively. It helps patients handle tremors, stiffness, and dyskinesias without fully relying on high doses of medications. It is employed in the treatment of Tourette syndrome, Huntington's disease, chorea, cluster headaches, and chronic pain. It is also utilized when medications are no longer effective for patients in maintaining a good quality of life. Furthermore, as DBS directly alters brain activity in a controlled manner, it is recommended by neurosurgeons, neurologists, neuropsychologists, and psychiatrists around the world.

Deep Brain Stimulation Market Trends

At present, the increasing demand for DBS due to the rising occurrence of various motor and neurological disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing acceptance of minimally invasive (MI) surgical methods to reduce post-operative scarring, minimize the cost of medical bills, and decrease the duration of hospital stays is offering a favorable market outlook. Additionally, there is an increase in the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe. This, along with the rising number of advancements made in improving the treatment and diagnosis of various neurological and psychological disorders, is propelling the growth of the market. Apart from this, the increasing awareness about the benefits of DBS and early detection of neurological complications, along with the rising geriatric population worldwide, is supporting the growth of the market. In addition, the rising occurrence of various lifestyle disorders and hypertension-induced depression among working individuals is strengthening the market growth. Moreover, key market players are incorporating artificial intelligence (AI) and the internet of things (IoT) in DBS systems to create robot-assisted implantations and multitarget stimulations.

Market Segmentation

This report provides an analysis of the key trends in each segment of the global deep brain stimulation market report, along with forecasts at the global and regional level from 2026-2034. The report has categorized the market based on stimulation type, product, application, and end-user.

Stimulation Type Insights

• Subthalamic DBS
• Globus Pallidus DBS
• Thalamic DBS
• Pedunculopontine Nucleus DBS

Product Insights

• Single Channel Deep Brain Stimulator
• Dual Channel Deep Brain Stimulator

Application Insights

• Parkinson's Disease (PD)
• Epilepsy
• Dystonia
• Obsessive Compulsive Disorder (OCD)
• Others

End-User Insights

• Hospitals
• Ambulatory Surgical Centers
• Neurological Centers
• Others

Regional Insights

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for deep brain stimulation. Some of the factors driving the North America deep brain stimulation market included the growing investment in the medical sector, rising construction of healthcare facilities, increasing occurrence of various neurological conditions among the masses, etc.

Competitive Landscape

The report provides a comprehensive analysis of the competitive landscape in the global deep brain stimulation market with detailed profiles of all major companies, including:

• Abbott Laboratories
• Aleva Neurotherapeutics
• Alpha Omega
• Beijing PINS Medical Co., Ltd.
• Boston Scientific Corporation
• Medtronic plc
• Newronika S.p.A.
• Renishaw PlC
• SceneRay Co., Ltd.

Key Questions Answered in This Report:

• How has the global deep brain stimulation market performed so far, and how will it perform in the coming years ?
• What are the drivers, restraints, and opportunities in the global deep brain stimulation market ?
• What is the impact of each driver, restraint, and opportunity on the global deep brain stimulation market ?
• What are the key regional markets ?
• Which countries represent the most attractive deep brain stimulation market ?
• What is the breakup of the market based on the stimulation type ?
• Which is the most attractive stimulation type in the deep brain stimulation market ?
• What is the breakup of the market based on the product ?
• Which is the most attractive product in the deep brain stimulation market ?
• What is the breakup of the market based on the application ?
• Which is the most attractive application in the deep brain stimulation market ?
• What is the breakup of the market based on the end-user ?
• Which is the most attractive end-user in the deep brain stimulation market ?
• What is the competitive structure of the global deep brain stimulation market ?
• Who are the key players/companies in the global deep brain stimulation market ?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Deep Brain Stimulation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Stimulation Type
• 5.5 Market Breakup by Product
• 5.6 Market Breakup by Application
• 5.7 Market Breakup by End-User
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Stimulation Type

• 6.1 Subthalamic DBS
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Globus Pallidus DBS
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Thalamic DBS
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Pedunculopontine Nucleus DBS
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Product

• 7.1 Single Channel Deep Brain Stimulator
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Dual Channel Deep Brain Stimulator
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Parkinson's Disease (PD)
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Epilepsy
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Dystonia
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Obsessive Compulsive Disorder (OCD)
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Neurological Centers
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Europe
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porter's Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
  • 15.3.2 Aleva Neurotherapeutics
  • 15.3.3 Alpha Omega
  • 15.3.4 Beijing PINS Medical Co., Ltd.
  • 15.3.5 Boston Scientific Corporation
  • 15.3.6 Medtronic plc
  • 15.3.7 Newronika S.p.A.
  • 15.3.8 Renishaw PlC
  • 15.3.9 SceneRay Co., Ltd.